Hydroxyurea

Hydroxyurea

Form: Capsules and Tablets

Strength: Capsules: 200 mg, 300 mg, 400 mg, 500 mg; Tablets: 100 mg, 500 mg, 1,000 mg

Reference Brands: Hydrea, Droxia , Siklos

Category: Anemia

Hydroxyurea is a widely used oral chemotherapeutic and hematologic drug indicated for sickle cell disease, chronic myeloid leukemia (CML), polycythemia vera, and essential thrombocythemia. It works by inhibiting DNA synthesis and increasing fetal hemoglobin (HbF) in sickle cell patients. Marketed under brands like Hydrea, Droxia, and Siklos, it is available in 100 mg to 500 mg capsules and tablets. Manufactured under GMP standards, Hydroxyurea is ideal for pharmaceutical distributors, hospitals, and global B2B buyers. We offer competitive pricing, regulatory documentation, and reliable bulk supply. Contact us today for high-quality Hydroxyurea sourcing and international export support.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Deferoxamine

Strength: 500 mg/vial, 2 g/vial

Form: Lyophilized powder for injection

Reference Brands: Desferal

View Details Get Enquiry
Deferasirox

Strength: 125 mg, 250 mg, 500 mg

Form: Tablets for Oral Suspension

Reference Brands: Exjade, Jadenu (film-coated)

View Details Get Enquiry
Iron(III)-Isomaltoside Injection

Strength: 100mg/ml

Form: Injection

Reference Brands: Monofer,, Diafer, Monoferric

View Details Get Enquiry
Iron Dextran

Strength: 50 mg/mL

Form: injection

Reference Brands: Dexferrum,INFeD

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.